Literature DB >> 28411363

Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical Relevance.

Bin Gao, Ming-Jiang Xu, Adeline Bertola, Hua Wang, Zhou Zhou, Suthat Liangpunsakul.   

Abstract

Alcoholic liver disease (ALD), a leading cause of chronic liver injury worldwide, comprises a range of disorders including simple steatosis, steatohepatitis, cirrhosis, and hepatocellular carcinoma. Over the last five decades, many animal models for the study of ALD pathogenesis have been developed. Recently, a chronic-plus-binge ethanol feeding model was reported. This model induces significant steatosis, hepatic neutrophil infiltration, and liver injury. A clinically relevant model of high-fat diet feeding plus binge ethanol was also developed, which highlights the risk of excessive binge drinking in obese/overweight individuals. All of these models recapitulate some features of the different stages of ALD and have been widely used by many investigators to study the pathogenesis of ALD and to test for therapeutic drugs/components. However, these models are somewhat variable, depending on mouse genetic background, ethanol dose, and animal facility environment. This review focuses on these models and discusses these variations and some methods to improve the feeding protocol. The pathogenesis, clinical relevance, and translational studies of these models are also discussed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28411363      PMCID: PMC5500917          DOI: 10.3727/105221617X695519

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  104 in total

1.  Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration.

Authors:  Stephanie Mathews; Dechun Feng; Igor Maricic; Cynthia Ju; Vipin Kumar; Bin Gao
Journal:  Cell Mol Immunol       Date:  2015-02-09       Impact factor: 11.530

2.  Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.

Authors:  Qi Gong; Zhimin Hu; Feifei Zhang; Aoyuan Cui; Xin Chen; Haoyang Jiang; Jing Gao; Xuqing Chen; Yamei Han; Qingning Liang; Dewei Ye; Lei Shi; Y Eugene Chin; Yu Wang; Hui Xiao; Feifan Guo; Yong Liu; Mengwei Zang; Aimin Xu; Yu Li
Journal:  Hepatology       Date:  2016-04-15       Impact factor: 17.425

3.  Hyperoxidized albumin modulates neutrophils to induce oxidative stress and inflammation in severe alcoholic hepatitis.

Authors:  Sukanta Das; Jaswinder Singh Maras; Md Shabir Hussain; Shvetank Sharma; Paul David; Sukriti Sukriti; Saggere Muralikrishna Shasthry; Rakhi Maiwall; Nirupama Trehanpati; Tej P Singh; Shiv Kumar Sarin
Journal:  Hepatology       Date:  2016-12-19       Impact factor: 17.425

4.  Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice.

Authors:  Raul Lazaro; Raymond Wu; Sunyoung Lee; Nian-Ling Zhu; Chia-Lin Chen; Samuel W French; Jun Xu; Keigo Machida; Hidekazu Tsukamoto
Journal:  Hepatology       Date:  2014-11-25       Impact factor: 17.425

Review 5.  Gut-liver axis in alcoholic liver disease.

Authors:  Gyongyi Szabo
Journal:  Gastroenterology       Date:  2014-11-11       Impact factor: 22.682

6.  A small RNA in neutrophils protects against acute-on-chronic alcoholic liver injury.

Authors:  Shaogui Wang; Wen-Xing Ding
Journal:  Gut       Date:  2016-10-08       Impact factor: 23.059

Review 7.  Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Herbert Tilg; Alexander R Moschen; Gyongyi Szabo
Journal:  Hepatology       Date:  2016-03-09       Impact factor: 17.425

8.  Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice.

Authors:  Dae Joong Kang; Naga S Betrapally; Siddhartha A Ghosh; R Balfour Sartor; Phillip B Hylemon; Patrick M Gillevet; Arun J Sanyal; Douglas M Heuman; Daniel Carl; Huiping Zhou; Runping Liu; Xiang Wang; Jing Yang; Chunhua Jiao; Jeremy Herzog; H Robert Lippman; Masoumeh Sikaroodi; Robert R Brown; Jasmohan S Bajaj
Journal:  Hepatology       Date:  2016-07-29       Impact factor: 17.425

9.  The Detrimental Role Played by Lipocalin-2 in Alcoholic Fatty Liver in Mice.

Authors:  Yan Cai; Alvin Jogasuria; Huquan Yin; Ming-Jiang Xu; Xudong Hu; Jiayou Wang; Chunki Kim; Jiashin Wu; Kwangwon Lee; Bin Gao; Min You
Journal:  Am J Pathol       Date:  2016-07-15       Impact factor: 4.307

10.  Myeloid Cell-Specific Lipin-1 Deficiency Stimulates Endocrine Adiponectin-FGF15 Axis and Ameliorates Ethanol-Induced Liver Injury in Mice.

Authors:  Jiayou Wang; Chunki Kim; Alvin Jogasuria; Yoonhee Han; Xudong Hu; Jiashin Wu; Hong Shen; Roman Chrast; Brian N Finck; Min You
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

View more
  34 in total

Review 1.  Preclinical models of non-alcoholic fatty liver disease.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Arun J Sanyal
Journal:  J Hepatol       Date:  2017-11-09       Impact factor: 25.083

2.  Hepatocyte-Macrophage Acetoacetate Shuttle Protects against Tissue Fibrosis.

Authors:  Patrycja Puchalska; Shannon E Martin; Xiaojing Huang; Justin E Lengfeld; Bence Daniel; Mark J Graham; Xianlin Han; Laszlo Nagy; Gary J Patti; Peter A Crawford
Journal:  Cell Metab       Date:  2018-11-15       Impact factor: 27.287

3.  Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12.

Authors:  Juan P Arab; Daniel Cabrera; Tejasav S Sehrawat; Nidhi Jalan-Sakrikar; Vikas K Verma; Douglas Simonetto; Sheng Cao; Usman Yaqoob; Jonathan Leon; Mariela Freire; Jose I Vargas; Thiago M De Assuncao; Jung H Kwon; Yi Guo; Enis Kostallari; Qing Cai; Tatiana Kisseleva; Youngman Oh; Marco Arrese; Robert C Huebert; Vijay H Shah
Journal:  J Hepatol       Date:  2020-02-20       Impact factor: 25.083

Review 4.  Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting.

Authors:  Matias A Avila; Jean-François Dufour; Alexander L Gerbes; Fabien Zoulim; Ramon Bataller; Patrizia Burra; Helena Cortez-Pinto; Bin Gao; Ian Gilmore; Philippe Mathurin; Christophe Moreno; Vladimir Poznyak; Bernd Schnabl; Gyongyi Szabo; Maja Thiele; Mark R Thursz
Journal:  Gut       Date:  2019-12-26       Impact factor: 23.059

5.  Flightless-I is a potential biomarker for the early detection of alcoholic liver disease.

Authors:  Jaime Arellanes-Robledo; Joseph Ibrahim; Karina Reyes-Gordillo; Ruchi Shah; Leslie Leckey; M Raj Lakshman
Journal:  Biochem Pharmacol       Date:  2020-11-07       Impact factor: 5.858

Review 6.  Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues.

Authors:  Rolf Teschke; Jack Uetrecht
Journal:  Ann Transl Med       Date:  2021-04

7.  Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein.

Authors:  Martin J Ronis; Kelly E Mercer; Kartik Shankar; Casey Pulliam; Kim Pedersen; Magnus Ingelman-Sundberg; Simonetta Friso; Derrick Samuelson; Luis Del Valle; Chris Taylor; David A Welsh
Journal:  Chem Biol Interact       Date:  2020-05-14       Impact factor: 5.192

Review 8.  A mini-review of the rodent models for alcoholic liver disease: shortcomings, application, and future prospects.

Authors:  Shi-Xuan Liu; Yan-Chao Du; Tao Zeng
Journal:  Toxicol Res (Camb)       Date:  2021-05-10       Impact factor: 3.524

Review 9.  Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.

Authors:  Szu-Yi Liu; I-Ting Tsai; Yin-Chou Hsu
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

Review 10.  Pathophysiological Aspects of Alcohol Metabolism in the Liver.

Authors:  Jeongeun Hyun; Jinsol Han; Chanbin Lee; Myunghee Yoon; Youngmi Jung
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.